Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine regimens in pregnant women with malaria
NCT01916954Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Jul 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of artemether, lumefantrine in Plasmodium falciparum malaria, sponsored by University of Oxford. Started Jul 2013; status: completed.
02
Drugs
artemetherlumefantrine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT01916954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01916954.